Global Statin Market (2019-2023) is Forecast to Register a CAGR of Over 2% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 7, 2018--The “Global Statin Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The statin market will register a CAGR of over 2% by 2023.
The increasing statin use will help the market grow at a steady rate. In the US and the UK, people aged 40 and above are recommended to monitor their cholesterol level. Statins are considered an evidence-based treatment for high risk patients with elevated cardiovascular disorder.
Rising prevalence of hypercholesterolemia
The rising prevalence of hypercholesterolemia is fueling the demand for generic cholesterol medications. Cardiovascular disease is one of the primary causes of mortality in Western countries.
Fierce generic competition
Patient expiration is a major challenge for companies developing branded drugs as it provides an opportunity for the development of generic drugs.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY TYPE
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY APPLICATION
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/research/nv3v3x/global_statin?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005430/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/07/2018 12:49 PM/DISC: 12/07/2018 12:49 PM